Community Healthcare Trust (CHCT) Financials

$15.87 -0.14 (-0.87%)

Closing price 05/23/2025 03:59 PM Eastern

Extended Trading

$15.85 -0.02 (-0.13%)

As of 05/23/2025 04:04 PM Eastern

Annual Income Statements for Community Healthcare Trust

This table shows Community Healthcare Trust's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-3.18	7.71	22
Consolidated Net Income / (Loss)	-3.18	7.71	22
Net Income / (Loss) Continuing Operations	-3.18	7.71	22
Total Pre-Tax Income	-3.18	8.02	22
Total Revenue	93	96	86
Net Interest Income / (Expense)	-23	-17	-12
Total Interest Income	0.53	0.81	0.07
Other Interest Income	0.53	0.81	0.07
Total Interest Expense	24	18	12
Long-Term Debt Interest Expense	24	18	12
Total Non-Interest Income	116	113	98
Other Service Charges	1.22	4.16	3.58
Other Non-Interest Income	115	109	94
Provision for Credit Losses	11	0.00	0.00
Total Non-Interest Expense	85	88	64
Property & Liability Insurance Claims	23	21	17
Other Operating Expenses	19	27	15
Depreciation Expense	43	40	32
Impairment Charge	0.12	0.10	0.00
Income Tax Expense	0.00	0.31	0.04
Basic Earnings per Share	($0.23)	$0.20	$0.81
Weighted Average Basic Shares Outstanding	26.53M	25.20M	23.63M
Diluted Earnings per Share	($0.23)	$0.20	$0.81
Weighted Average Diluted Shares Outstanding	26.53M	25.20M	23.63M
Weighted Average Basic & Diluted Shares Outstanding	28.34M	27.68M	26.02M
Cash Dividends to Common per Share	$1.85	$1.81	$1.77

This table shows Community Healthcare Trust's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	1.83	1.75	-10	3.67	4.57	3.49	6.58	-6.92	5.24	5.67
Consolidated Net Income / (Loss)	1.83	1.75	-10	3.67	4.57	3.49	6.58	-6.92	5.24	5.67
Net Income / (Loss) Continuing Operations	1.83	1.75	-10	3.67	4.57	3.49	6.58	-6.92	5.22	5.67
Total Pre-Tax Income	1.84	1.74	-10	3.67	4.47	3.82	6.63	-6.89	2.63	5.69
Total Revenue	11	30	28	24	24	24	24	23	22	22
Net Interest Income / (Expense)	-19	0.21	0.31	-5.06	-4.98	-4.64	-3.39	-3.97	-3.46	-3.02
Total Interest Income	0.02	0.21	0.31	0.00	0.04	0.00	0.75	0.03	0.00	0.01
Total Interest Expense	19	0.00	0.00	5.06	5.02	4.64	4.14	3.99	3.46	3.03
Total Non-Interest Income	29	30	28	29	29	29	28	27	25	25
Other Service Charges	0.32	0.30	-0.39	0.99	1.02	1.05	1.05	1.05	0.96	0.89
Other Non-Interest Income	29	29	28	28	28	28	27	26	24	24
Total Non-Interest Expense	21	22	21	21	20	20	18	30	17	16
Property & Liability Insurance Claims	5.49	5.99	5.57	5.79	5.60	5.46	4.79	4.87	4.16	4.33
Other Operating Expenses	4.81	4.94	4.76	4.55	3.73	3.62	3.79	16	4.15	3.76
Depreciation Expense	11	11	11	10	10	11	9.22	9.02	8.32	8.00
Basic Earnings per Share	$0.04	$0.04	($0.42)	$0.11	$0.17	$0.11	$0.24	($0.32)	$0.18	$0.21
Weighted Average Basic Shares Outstanding	26.53M	26.66M	26.48M	26.30M	25.20M	25.51M	25.07M	24.23M	23.63M	23.59M
Diluted Earnings per Share	$0.04	$0.04	($0.42)	$0.11	$0.17	$0.11	$0.24	($0.32)	$0.18	$0.21
Weighted Average Diluted Shares Outstanding	26.53M	26.66M	26.48M	26.30M	25.20M	25.51M	25.07M	24.23M	23.63M	23.59M
Weighted Average Basic & Diluted Shares Outstanding	28.34M	28.24M	28.06M	27.70M	27.68M	27.26M	26.56M	26.30M	26.02M	25.30M

This table details how cash moves in and out of Community Healthcare Trust's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	-0.25	-7.44	9.20
Net Cash From Operating Activities	59	61	60
Net Cash From Continuing Operating Activities	59	61	60
Net Income / (Loss) Continuing Operations	-3.18	7.71	22
Consolidated Net Income / (Loss)	-3.18	7.71	22
Provision For Loan Losses	11	0.00	0.00
Depreciation Expense	43	40	32
Amortization Expense	0.93	13	0.85
Non-Cash Adjustments to Reconcile Net Income	8.17	4.82	6.01
Changes in Operating Assets and Liabilities, net	-0.81	-3.39	-0.94
Net Cash From Investing Activities	-93	-114	-114
Net Cash From Continuing Investing Activities	-92	-114	-113
Purchase of Property, Leasehold Improvements and Equipment	-25	-19	-10
Purchase of Investment Securities	-75	-101	-106
Sale and/or Maturity of Investments	7.42	6.19	3.00
Other Investing Activities, net	0.22	-	0.67
Net Cash From Financing Activities	34	45	63
Net Cash From Continuing Financing Activities	34	45	63
Issuance of Debt	162	50	150
Issuance of Common Equity	7.49	44	21
Repayment of Debt	-83	-0.13	-63
Payment of Dividends	-52	-48	-44
Other Financing Activities, Net	-1.01	-1.19	-0.39
Cash Interest Paid	23	18	11

This table details how cash moves in and out of Community Healthcare Trust's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	1.55	2.10	-4.21	0.31	-0.30	1.26	-0.95	-7.44	8.73	0.98
Net Cash From Operating Activities	16	14	17	13	14	18	17	13	15	15
Net Cash From Continuing Operating Activities	16	14	17	13	14	18	17	13	15	15
Net Income / (Loss) Continuing Operations	1.83	1.75	-10	3.67	4.57	3.49	6.58	-6.92	5.24	5.67
Consolidated Net Income / (Loss)	1.83	1.75	-10	3.67	4.57	3.49	6.58	-6.92	5.24	5.67
Depreciation Expense	11	11	11	10	10	11	9.22	9.02	8.32	8.00
Amortization Expense	0.29	0.25	0.17	0.22	0.19	0.05	0.24	12	0.23	0.21
Non-Cash Adjustments to Reconcile Net Income	1.87	1.81	2.81	1.67	1.16	1.78	0.22	1.67	1.81	1.63
Changes in Operating Assets and Liabilities, net	0.87	-0.90	2.38	-3.17	-1.87	1.19	0.42	-3.13	-0.18	-0.16
Net Cash From Investing Activities	-9.49	-14	-30	-39	-14	-55	-16	-29	-58	-22
Net Cash From Continuing Investing Activities	-9.43	-14	-30	-39	-14	-55	-16	-29	-57	-22
Purchase of Property, Leasehold Improvements and Equipment	-5.16	-7.19	-7.19	-5.11	-7.52	-3.58	-3.75	-4.14	-3.68	-3.05
Purchase of Investment Securities	-8.42	-8.91	-24	-34	-6.90	-52	-17	-25	-55	-20
Sale and/or Maturity of Investments	4.09	1.72	0.75	0.87	0.87	0.79	3.78	0.75	0.75	0.75
Other Investing Activities, net	0.06	0.08	0.05	0.03	-	-	-	-	-	-
Net Cash From Financing Activities	-4.63	2.64	9.32	26	-1.04	39	-1.15	8.44	51	7.73
Net Cash From Continuing Financing Activities	-4.63	2.64	9.32	26	-1.04	39	-1.15	8.44	51	7.73
Issuance of Debt	87	16	20	39	2.00	33	3.00	12	105	19
Repayment of Debt	-78	-	-4.79	-0.03	-0.03	-0.03	-0.03	-0.03	-63	-0.03
Payment of Dividends	-13	-13	-13	-13	-12	-12	-12	-12	-11	-11
Other Financing Activities, Net	-0.05	-0.29	-0.06	-0.61	-0.05	-0.04	-1.01	-0.10	-0.21	-0.05
Cash Interest Paid	6.14	6.23	5.91	4.79	7.34	2.17	4.16	4.06	3.21	2.61

This table presents Community Healthcare Trust's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	993	945	876
Cash and Due from Banks	4.38	3.49	11
Restricted Cash	0.00	1.14	0.84
Loans and Leases, Net of Allowance	0.00	0.00	0.00
Premises and Equipment, Net	903	849	778
Other Assets	85	91	87
Total Liabilities & Shareholders' Equity	993	945	876
Total Liabilities	517	432	380
Other Short-Term Payables	14	12	11
Long-Term Debt	486	403	353
Other Long-Term Liabilities	16	17	15
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	476	513	497
Total Preferred & Common Equity	476	513	497
Preferred Stock	0.00	0.00	0.00
Total Common Equity	476	513	497
Common Stock	705	688	625
Retained Earnings	-246	-192	-151
Accumulated Other Comprehensive Income / (Loss)	18	16	23

This table presents Community Healthcare Trust's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	982	983	983	955	900	886	812
Cash and Due from Banks	2.84	0.73	3.81	3.89	2.63	3.67	2.66
Restricted Cash	0.00	0.00	1.14	1.05	1.05	0.96	0.68
Loans and Leases, Net of Allowance	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Premises and Equipment, Net	903	899	880	852	805	797	730
Other Assets	76	84	98	98	92	85	79
Total Liabilities & Shareholders' Equity	982	983	983	955	900	886	812
Total Liabilities	505	485	471	433	395	392	333
Other Short-Term Payables	14	12	12	15	11	10	8.14
Long-Term Debt	474	458	442	401	368	365	311
Other Long-Term Liabilities	16	16	17	16	16	16	15
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	477	498	512	522	505	495	478
Total Preferred & Common Equity	477	498	512	522	505	495	478
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	477	498	512	522	505	495	478
Common Stock	702	700	691	677	657	649	602
Retained Earnings	-235	-224	-201	-184	-175	-170	-145
Accumulated Other Comprehensive Income / (Loss)	10	21	21	29	23	16	21

This table displays calculated financial ratios and metrics derived from Community Healthcare Trust's official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	-3.40%	11.64%	7.21%
EBITDA Growth	-32.75%	9.06%	2.99%
EBIT Growth	-139.66%	-63.64%	-1.61%
NOPAT Growth	-128.87%	-64.97%	-1.80%
Net Income Growth	-141.24%	-64.97%	-2.10%
EPS Growth	-215.00%	-75.31%	-6.90%
Operating Cash Flow Growth	-4.08%	1.83%	6.98%
Free Cash Flow Firm Growth	19.25%	41.05%	-58.75%
Invested Capital Growth	4.95%	7.85%	16.77%
Revenue Q/Q Growth	-12.70%	2.41%	1.69%
EBITDA Q/Q Growth	-25.01%	1.86%	-0.31%
EBIT Q/Q Growth	-113.96%	-9.01%	-2.99%
NOPAT Q/Q Growth	-605.32%	24.64%	9.37%
Net Income Q/Q Growth	-613.23%	-8.00%	-3.82%
EPS Q/Q Growth	-130.00%	-4.76%	-6.90%
Operating Cash Flow Q/Q Growth	2.39%	-1.79%	0.69%
Free Cash Flow Firm Q/Q Growth	-71.98%	53.93%	-100.50%
Invested Capital Q/Q Growth	1.16%	-0.76%	7.67%
Profitability Metrics	-	-	-
EBITDA Margin	43.76%	62.86%	64.34%
EBIT Margin	-3.43%	8.37%	25.69%
Profit (Net Income) Margin	-3.43%	8.05%	25.64%
Tax Burden Percent	100.00%	96.18%	99.81%
Interest Burden Percent	100.00%	100.00%	100.00%
Effective Tax Rate	0.00%	3.82%	0.19%
Return on Invested Capital (ROIC)	-0.24%	0.87%	2.79%
ROIC Less NNEP Spread (ROIC-NNEP)	-0.45%	0.87%	2.79%
Return on Net Nonoperating Assets (RNNOA)	-0.41%	0.65%	1.80%
Return on Equity (ROE)	-0.64%	1.53%	4.59%
Cash Return on Invested Capital (CROIC)	-5.07%	-6.68%	-12.68%
Operating Return on Assets (OROA)	-0.33%	0.88%	2.71%
Return on Assets (ROA)	-0.33%	0.85%	2.70%
Return on Common Equity (ROCE)	-0.64%	1.53%	4.59%
Return on Equity Simple (ROE_SIMPLE)	-0.67%	1.50%	4.43%
Net Operating Profit after Tax (NOPAT)	-2.23	7.71	22
NOPAT Margin	-2.40%	8.05%	25.64%
Net Nonoperating Expense Percent (NNEP)	0.21%	0.00%	0.00%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	91.56%	91.63%	74.31%
Earnings before Interest and Taxes (EBIT)	-3.18	8.02	22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	41	60	55
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	1.14	1.30	1.59
Price to Tangible Book Value (P/TBV)	1.14	1.30	1.59
Price to Revenue (P/Rev)	5.86	6.96	9.18
Price to Earnings (P/E)	0.00	86.48	35.82
Dividend Yield	9.60%	7.38%	5.66%
Earnings Yield	0.00%	1.16%	2.79%
Enterprise Value to Invested Capital (EV/IC)	1.06	1.16	1.33
Enterprise Value to Revenue (EV/Rev)	11.06	11.12	13.15
Enterprise Value to EBITDA (EV/EBITDA)	25.27	17.69	20.44
Enterprise Value to EBIT (EV/EBIT)	0.00	132.88	51.20
Enterprise Value to NOPAT (EV/NOPAT)	0.00	138.15	51.30
Enterprise Value to Operating Cash Flow (EV/OCF)	17.39	17.36	18.74
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	1.02	0.79	0.71
Long-Term Debt to Equity	1.02	0.79	0.71
Financial Leverage	0.90	0.75	0.65
Leverage Ratio	1.96	1.80	1.70
Compound Leverage Factor	1.96	1.80	1.70
Debt to Total Capital	50.52%	44.00%	41.54%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	50.52%	44.00%	41.54%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	49.48%	56.00%	58.46%
Debt to EBITDA	11.99	6.69	6.39
Net Debt to EBITDA	11.88	6.62	6.17
Long-Term Debt to EBITDA	11.99	6.69	6.39
Debt to NOPAT	-218.24	52.28	16.03
Net Debt to NOPAT	-216.27	51.68	15.48
Long-Term Debt to NOPAT	-218.24	52.28	16.03
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-48	-59	-100
Operating Cash Flow to CapEx	238.93%	323.39%	580.96%
Free Cash Flow to Firm to Interest Expense	-2.01	-3.32	-8.43
Operating Cash Flow to Interest Expense	2.48	3.45	5.08
Operating Cash Flow Less CapEx to Interest Expense	1.44	2.38	4.20
Efficiency Ratios	-	-	-
Asset Turnover	0.10	0.11	0.11
Fixed Asset Turnover	0.11	0.12	0.12
Capital & Investment Metrics	-	-	-
Invested Capital	962	917	850
Invested Capital Turnover	0.10	0.11	0.11
Increase / (Decrease) in Invested Capital	45	67	122
Enterprise Value (EV)	1,024	1,066	1,130
Market Capitalization	543	667	789
Book Value per Share	$16.85	$18.83	$19.64
Tangible Book Value per Share	$16.85	$18.83	$19.64
Total Capital	962	917	850
Total Debt	486	403	353
Total Long-Term Debt	486	403	353
Net Debt	482	399	341
Capital Expenditures (CapEx)	25	19	10
Net Nonoperating Expense (NNE)	0.95	0.00	0.00
Net Nonoperating Obligations (NNO)	486	403	353
Total Depreciation and Amortization (D&A)	44	52	33
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($0.23)	$0.20	$0.81
Adjusted Weighted Average Basic Shares Outstanding	26.53M	25.20M	23.63M
Adjusted Diluted Earnings per Share	($0.23)	$0.20	$0.81
Adjusted Weighted Average Diluted Shares Outstanding	26.53M	25.20M	23.63M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	28.34M	27.68M	26.02M
Normalized Net Operating Profit after Tax (NOPAT)	-2.14	7.81	22
Normalized NOPAT Margin	-2.31%	8.15%	25.64%
Pre Tax Income Margin	-3.43%	8.37%	25.69%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-0.13	0.45	1.86
NOPAT to Interest Expense	-0.09	0.43	1.85
EBIT Less CapEx to Interest Expense	-1.17	-0.62	0.98
NOPAT Less CapEx to Interest Expense	-1.13	-0.63	0.98
Payout Ratios	-	-	-
Dividend Payout Ratio	-1,625.21%	623.01%	202.03%
Augmented Payout Ratio	-1,625.21%	623.01%	202.03%

This table displays calculated financial ratios and metrics derived from Community Healthcare Trust's official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-55.80%	23.85%	13.94%	4.58%	10.33%	10.61%	14.38%	11.28%	6.98%	6.44%
EBITDA Growth	-95.40%	27.22%	-59.49%	-0.36%	7.96%	8.40%	15.92%	3.88%	-1.22%	3.67%
EBIT Growth	-332.97%	109.62%	-167.01%	153.22%	-15.10%	-33.00%	18.34%	-225.06%	-11.45%	5.46%
NOPAT Growth	-58.86%	122.51%	-147.27%	176.02%	69.51%	-36.65%	17.45%	-159.16%	272.56%	-30.31%
Net Income Growth	-59.89%	-49.91%	-258.54%	152.95%	-12.81%	-38.45%	17.78%	-225.31%	-14.31%	5.96%
EPS Growth	-76.47%	-63.64%	-275.00%	134.38%	-5.56%	-47.62%	14.29%	-252.38%	-25.00%	5.00%
Operating Cash Flow Growth	9.60%	-21.85%	0.32%	-0.43%	-7.26%	15.41%	10.31%	-11.83%	2.77%	15.85%
Free Cash Flow Firm Growth	29.99%	85.16%	16.77%	26.61%	47.89%	-102.95%	-134.76%	-459.26%	-40.95%	47.30%
Invested Capital Growth	4.95%	2.97%	9.38%	10.98%	7.85%	17.01%	14.22%	16.04%	16.77%	9.74%
Revenue Q/Q Growth	-64.25%	7.27%	14.63%	0.54%	0.18%	-1.32%	5.21%	6.07%	0.44%	2.05%
EBITDA Q/Q Growth	-96.42%	194.20%	-53.92%	-6.36%	-1.14%	-6.31%	13.34%	2.85%	-0.74%	0.18%
EBIT Q/Q Growth	-230.07%	280.07%	-221.17%	-21.50%	17.04%	-42.43%	196.22%	-230.96%	-7.64%	1.68%
NOPAT Q/Q Growth	-77.03%	357.25%	-184.82%	-21.50%	24.23%	-45.36%	236.43%	-283.03%	-53.57%	1.30%
Net Income Q/Q Growth	4.75%	116.77%	-384.50%	-19.75%	30.78%	-46.91%	195.02%	-232.15%	-7.67%	1.59%
EPS Q/Q Growth	0.00%	109.52%	-481.82%	-35.29%	54.55%	-54.17%	175.00%	-277.78%	-14.29%	0.00%
Operating Cash Flow Q/Q Growth	13.14%	-17.24%	32.32%	-11.54%	-19.33%	6.24%	31.33%	-17.60%	0.38%	1.55%
Free Cash Flow Firm Q/Q Growth	-124.77%	77.21%	6.25%	-46.26%	52.36%	-27.83%	17.33%	-3.49%	-85.57%	-47.86%
Invested Capital Q/Q Growth	1.16%	-0.47%	0.15%	4.09%	-0.76%	5.73%	1.61%	1.15%	7.67%	3.21%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
EBITDA Margin	6.43%	64.25%	23.43%	58.27%	61.72%	62.55%	65.89%	61.16%	63.08%	63.83%
EBIT Margin	-97.49%	26.80%	-15.96%	15.10%	18.50%	15.83%	27.14%	-29.67%	24.03%	26.14%
Profit (Net Income) Margin	17.17%	5.86%	-37.48%	15.10%	18.92%	14.49%	26.93%	-29.82%	23.94%	26.04%
Tax Burden Percent	99.73%	100.29%	100.00%	100.00%	102.28%	91.53%	99.25%	100.51%	198.86%	99.63%
Interest Burden Percent	-17.66%	21.81%	234.79%	100.00%	100.00%	100.00%	100.00%	100.00%	50.09%	100.00%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	5.79%	0.75%	0.00%	0.00%	0.37%
Return on Invested Capital (ROIC)	1.70%	3.03%	-1.23%	1.61%	2.01%	1.63%	3.00%	-2.29%	1.31%	2.92%
ROIC Less NNEP Spread (ROIC-NNEP)	1.70%	1.60%	-3.00%	1.61%	2.03%	1.60%	3.00%	-2.95%	2.15%	2.92%
Return on Net Nonoperating Assets (RNNOA)	1.53%	1.40%	-2.47%	1.30%	1.52%	1.14%	2.02%	-1.94%	1.39%	1.76%
Return on Equity (ROE)	3.22%	4.44%	-3.69%	2.91%	3.53%	2.77%	5.03%	-4.23%	2.70%	4.68%
Cash Return on Invested Capital (CROIC)	-5.07%	-2.96%	-8.78%	-8.38%	-6.68%	-14.95%	-12.29%	-13.97%	-12.68%	-6.62%
Operating Return on Assets (OROA)	-9.32%	2.94%	-1.70%	1.57%	1.95%	1.68%	2.94%	-3.18%	2.53%	2.83%
Return on Assets (ROA)	1.64%	0.64%	-3.99%	1.57%	1.99%	1.54%	2.92%	-3.19%	2.52%	2.82%
Return on Common Equity (ROCE)	3.22%	4.44%	-3.69%	2.91%	3.53%	2.77%	5.03%	-4.23%	2.70%	4.68%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-0.09%	0.26%	3.58%	0.00%	1.61%	2.09%	1.94%	0.00%	4.78%
Net Operating Profit after Tax (NOPAT)	1.84	8.00	-3.11	3.67	4.47	3.59	6.58	-4.82	2.63	5.67
NOPAT Margin	17.22%	26.80%	-11.17%	15.10%	18.50%	14.91%	26.93%	-20.77%	12.04%	26.04%
Net Nonoperating Expense Percent (NNEP)	0.00%	1.43%	1.77%	0.00%	-0.03%	0.03%	0.00%	0.66%	-0.84%	0.00%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	197.49%	73.20%	76.43%	84.90%	81.50%	84.17%	72.86%	129.67%	75.97%	73.86%
Earnings before Interest and Taxes (EBIT)	-10	8.00	-4.44	3.67	4.47	3.82	6.63	-6.89	5.26	5.69
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	0.69	19	6.52	14	15	15	16	14	14	14
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.14	1.07	1.27	1.35	1.30	1.40	1.57	1.74	1.59	1.51
Price to Tangible Book Value (P/TBV)	1.14	1.07	1.27	1.35	1.30	1.40	1.57	1.74	1.59	1.51
Price to Revenue (P/Rev)	5.86	4.80	6.30	7.15	6.96	7.80	8.69	9.74	9.18	8.58
Price to Earnings (P/E)	0.00	0.00	451.84	37.65	86.48	87.07	75.12	89.79	35.82	31.64
Dividend Yield	9.60%	10.11%	8.00%	7.14%	7.38%	6.53%	5.92%	5.37%	5.66%	6.08%
Earnings Yield	0.00%	0.00%	0.22%	2.66%	1.16%	1.15%	1.33%	1.11%	2.79%	3.16%
Enterprise Value to Invested Capital (EV/IC)	1.06	1.03	1.14	1.18	1.16	1.22	1.33	1.42	1.33	1.31
Enterprise Value to Revenue (EV/Rev)	11.06	9.24	10.85	11.66	11.12	12.03	12.69	13.83	13.15	12.22
Enterprise Value to EBITDA (EV/EBITDA)	25.27	18.14	21.81	23.30	17.69	19.04	19.97	21.87	20.44	18.62
Enterprise Value to EBIT (EV/EBIT)	0.00	43.01	58.53	60.53	132.88	127.79	108.31	126.21	51.20	45.38
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	672.23	61.42	138.15	182.00	143.55	173.27	51.30	51.25
Enterprise Value to Operating Cash Flow (EV/OCF)	17.39	17.04	17.74	18.43	17.36	18.02	19.26	20.83	18.74	17.24
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.02	0.99	0.92	0.86	0.79	0.77	0.73	0.74	0.71	0.65
Long-Term Debt to Equity	1.02	0.99	0.92	0.86	0.79	0.77	0.73	0.74	0.71	0.65
Financial Leverage	0.90	0.88	0.82	0.80	0.75	0.71	0.67	0.66	0.65	0.60
Leverage Ratio	1.96	1.94	1.88	1.86	1.80	1.77	1.72	1.71	1.70	1.66
Compound Leverage Factor	-0.35	0.42	4.41	1.86	1.80	1.77	1.72	1.71	0.85	1.66
Debt to Total Capital	50.52%	49.82%	47.90%	46.37%	44.00%	43.44%	42.15%	42.47%	41.54%	39.38%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	50.52%	49.82%	47.90%	46.37%	44.00%	43.44%	42.15%	42.47%	41.54%	39.38%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	49.48%	50.18%	52.10%	53.63%	56.00%	56.56%	57.85%	57.53%	58.46%	60.62%
Debt to EBITDA	11.99	8.77	9.16	9.12	6.69	6.78	6.35	6.54	6.39	5.61
Net Debt to EBITDA	11.88	8.71	9.15	9.02	6.62	6.70	6.28	6.46	6.17	5.55
Long-Term Debt to EBITDA	11.99	8.77	9.16	9.12	6.69	6.78	6.35	6.54	6.39	5.61
Debt to NOPAT	-218.24	-1,500.53	282.48	24.04	52.28	64.82	45.63	51.85	16.03	15.44
Net Debt to NOPAT	-216.27	-1,491.54	282.03	23.77	51.68	64.03	45.17	51.19	15.48	15.27
Long-Term Debt to NOPAT	-218.24	-1,500.53	282.48	24.04	52.28	64.82	45.63	51.85	16.03	15.44
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-44	-19	-85	-91	-62	-131	-102	-124	-119	-64
Operating Cash Flow to CapEx	303.51%	192.69%	232.83%	247.27%	190.05%	495.30%	445.17%	306.86%	418.98%	503.31%
Free Cash Flow to Firm to Interest Expense	-2.34	0.00	0.00	-17.92	-12.40	-28.15	-24.68	-30.97	-34.48	-21.26
Operating Cash Flow to Interest Expense	0.84	0.00	0.00	2.50	2.85	3.82	4.03	3.18	4.45	5.07
Operating Cash Flow Less CapEx to Interest Expense	0.56	0.00	0.00	1.49	1.35	3.05	3.12	2.14	3.39	4.06
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.10	0.11	0.11	0.10	0.11	0.11	0.11	0.11	0.11	0.11
Fixed Asset Turnover	0.11	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.08
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	962	951	955	954	917	923	873	860	850	789
Invested Capital Turnover	0.10	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11
Increase / (Decrease) in Invested Capital	45	27	82	94	67	134	109	119	122	70
Enterprise Value (EV)	1,024	980	1,089	1,130	1,066	1,126	1,158	1,220	1,130	1,032
Market Capitalization	543	509	632	693	667	730	794	860	789	724
Book Value per Share	$16.85	$17.01	$17.97	$19.46	$18.83	$19.67	$19.21	$19.00	$19.64	$19.06
Tangible Book Value per Share	$16.85	$17.01	$17.97	$19.46	$18.83	$19.67	$19.21	$19.00	$19.64	$19.06
Total Capital	962	951	955	954	917	923	873	860	850	789
Total Debt	486	474	458	442	403	401	368	365	353	311
Total Long-Term Debt	486	474	458	442	403	401	368	365	353	311
Net Debt	482	471	457	437	399	396	364	360	341	307
Capital Expenditures (CapEx)	5.16	7.19	7.19	5.11	7.52	3.58	3.75	4.14	3.68	3.05
Net Nonoperating Expense (NNE)	0.01	6.25	7.32	0.00	-0.10	0.10	0.00	2.10	-2.60	0.00
Net Nonoperating Obligations (NNO)	486	474	458	442	403	401	368	365	353	311
Total Depreciation and Amortization (D&A)	11	11	11	10	10	11	9.46	21	8.54	8.21
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.04	$0.04	($0.42)	$0.11	$0.17	$0.11	$0.24	($0.32)	$0.18	$0.21
Adjusted Weighted Average Basic Shares Outstanding	26.53M	26.66M	26.48M	26.30M	25.20M	25.51M	25.07M	24.23M	23.63M	23.59M
Adjusted Diluted Earnings per Share	$0.04	$0.04	($0.42)	$0.11	$0.17	$0.11	$0.24	($0.32)	$0.18	$0.21
Adjusted Weighted Average Diluted Shares Outstanding	26.53M	26.66M	26.48M	26.30M	25.20M	25.51M	25.07M	24.23M	23.63M	23.59M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	28.34M	28.24M	28.06M	27.70M	27.68M	27.26M	26.56M	26.30M	26.02M	25.30M
Normalized Net Operating Profit after Tax (NOPAT)	1.29	5.60	-3.01	2.57	3.13	3.59	6.58	-4.82	1.84	5.67
Normalized NOPAT Margin	12.05%	18.76%	-10.82%	10.57%	12.95%	14.91%	26.93%	-20.77%	8.43%	26.04%
Pre Tax Income Margin	17.22%	5.84%	-37.48%	15.10%	18.50%	15.83%	27.14%	-29.67%	12.04%	26.14%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-0.56	0.00	0.00	0.72	0.89	0.82	1.60	-1.73	1.52	1.88
NOPAT to Interest Expense	0.10	0.00	0.00	0.72	0.89	0.77	1.59	-1.21	0.76	1.87
EBIT Less CapEx to Interest Expense	-0.83	0.00	0.00	-0.29	-0.61	0.05	0.70	-2.76	0.46	0.87
NOPAT Less CapEx to Interest Expense	-0.18	0.00	0.00	-0.29	-0.61	0.00	0.68	-2.24	-0.30	0.87
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-1,625.21%	-11,430.72%	3,858.67%	268.28%	623.01%	559.51%	435.05%	471.76%	202.03%	192.50%
Augmented Payout Ratio	-1,625.21%	-11,430.72%	3,858.67%	268.28%	623.01%	559.51%	435.05%	471.76%	202.03%	192.50%

Frequently Asked Questions About Community Healthcare Trust's Financials

When does Community Healthcare Trust's fiscal year end?

According to the most recent income statement we have on file, Community Healthcare Trust's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Community Healthcare Trust's net income changed over the last 2 years?

Community Healthcare Trust's net income appears to be on a downward trend, with a most recent value of -$3.18 million in 2024, falling from $22.02 million in 2022. The previous period was $7.71 million in 2023. See Community Healthcare Trust's forecast for analyst expectations on what’s next for the company.

How has Community Healthcare Trust revenue changed over the last 2 years?

Over the last 2 years, Community Healthcare Trust's total revenue changed from $85.87 million in 2022 to $92.61 million in 2024, a change of 7.8%.

How much debt does Community Healthcare Trust have?

Community Healthcare Trust's total liabilities were at $516.60 million at the end of 2024, a 19.5% increase from 2023, and a 36.1% increase since 2022.

How much cash does Community Healthcare Trust have?

In the past 2 years, Community Healthcare Trust's cash and equivalents has ranged from $3.49 million in 2023 to $11.23 million in 2022, and is currently $4.38 million as of their latest financial filing in 2024.

How has Community Healthcare Trust's book value per share changed over the last 2 years?

Over the last 2 years, Community Healthcare Trust's book value per share changed from 19.64 in 2022 to 16.85 in 2024, a change of -14.2%.

Related Companies

This page (NYSE:CHCT) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Community Healthcare Trust (CHCT) Financials

Frequently Asked Questions About Community Healthcare Trust's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Community Healthcare Trust (CHCT) Financials

Annual Income Statements for Community Healthcare Trust

Quarterly Income Statements for Community Healthcare Trust

Annual Cash Flow Statements for Community Healthcare Trust

Quarterly Cash Flow Statements for Community Healthcare Trust

Annual Balance Sheets for Community Healthcare Trust

Quarterly Balance Sheets for Community Healthcare Trust

Annual Metrics And Ratios for Community Healthcare Trust

Quarterly Metrics And Ratios for Community Healthcare Trust

Frequently Asked Questions About Community Healthcare Trust's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools